Is a nurse-led telephone intervention a viable alternative to nurse-led home care and standard care for patients receiving oral capecitabine? Results from a large prospective audit in patients with colorectal cancer

European Journal of Cancer Care

Volumn 22, Issue 3, 2013, Pages 413-419

  Craven, Olive ^a   Hughes, Carol Anne ^a   Burton, Amy ^b   Saunders, Mark P ^a   Molassiotis, Alex ^b  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Capecitabine; Colorectal cancer; Home care; Nurse led telephone intervention; Oral chemotherapy

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; CAPECITABINE; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL;

ADULT; AGED; AMBULATORY CARE; ANALYSIS OF VARIANCE; ARTICLE; COLORECTAL TUMOR; FEMALE; HEALTH CARE QUALITY; HOME CARE; HUMAN; LONGITUDINAL STUDY; MALE; MEDICAL AUDIT; METHODOLOGY; MIDDLE AGED; NURSING; NURSING PRACTICE; ORGANIZATION AND MANAGEMENT; PROSPECTIVE STUDY; STANDARD; TELEMEDICINE; TELEPHONE; UNITED KINGDOM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANALYSIS OF VARIANCE; ANTIMETABOLITES, ANTINEOPLASTIC; CLINICAL AUDIT; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; GREAT BRITAIN; HOME CARE SERVICES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NURSE'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; STANDARD OF CARE; TELEMEDICINE; TELEPHONE;

EID: 84876851569     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/ecc.12047     Document Type: Article

References (24)

1. Beaver K., Twomey M., Witham G.G., Foy S. & Luker K.A. (2006) Meeting the information needs of women with breastcancer: piloting a nurse led intervention. European Journal of Oncology Nursing 10, 378-390.
2. Bhansali M.S., Vaidya J.S., Bhatt R.G., Patil P.K., Badwe R.A. & Desai P.B. (1996) Chemotherapy for carcinoma of the esophagus: a comparison of evidence from meta-analysis of randomized trials and of historical control studies. Annals of Oncology 7, 355-359.
3. Brearley S.G., Craven O., Saunders M., Swindell R. & Molassiotis A. (2010) Clinical features of oral chemotherapy: results of a longitudinal prospective study of breast and colorectal cancer patients receiving capecitabine in the UK. European Journal of Cancer Care 19, 425-433.
4. Cancer Research UK (2008) Bowel (Colorectal) Cancer - UK Incidence Statistics. Available at: http://info.cancerresearchuk.org/cancerstats/types/bowel/incidence/.
5. Cox K. & Wilson E. (2003) Follow-up for people with cancer: nurse-led services and telephone interventions. Journal of Advanced Nursing 43, 51-61.
6. Foley D.J., Monjan A.A., Brown S.L., Simonsick E.M., Wallace R.B. & Blazer D.G. (1995) Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 18, 425-432.
7. Hearnshaw H., Harker R., Cheater F., Baker R. & Grimshaw G. (2002) A study of the methods used to select review criteria for clinical audit. Health Technology Assessment 6, 1-78.
8. Hirsch B.R. & Zagar S.Y. (2011) Capecitabine in the management of colorectal cancer. Cancer Management Research 3, 79-79.
9. Hoff P.M., Ansari R., Batist G., Cox J., Kocha W., Kuperminc M., Maroun J., Walde D., Weaver C., Harrison E., Burger H.U., Osterwalder B., Wong A.O. & Wong R. (2001) Comparison or oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. Journal of Clinical Oncology 19, 2282-2292.
10. Jweinat J.J. (2010) Hospital readmissions under the spotlight. Journal of Health Care Management 55, 252-264.
11. MacLeod A., Branch A., Cassidy J., McDonald A., Mohammed N. & MacDonald L. (2007) A nurse-/pharmacy-led capecitabine clinic for colorectal cancer: results of a prospective audit and retrospective survey of patient experiences. European Journal of Oncology Nursing 11, 247-254.
12. Molassiotis A., Brearley S., Saunders M., Craven O., Wardley A., Farrel C., Swindell R., Todd C. & Luker K. (2009) Effectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: a randomized, controlled trial. Journal of Clinical Oncology 36, 6191-6198.
13. National Cancer Institute (1998) Common Toxicity Criteria: Cancer Therapy Evaluation Program, Version 2.0. Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
14. National Institute for Clinical Excellence (2002) Principles for Best Practice in Clinical Audit. Radcliffe Medical Press, Oxford, UK.
15. National Institute for Clinical Excellence (2003) Capecitabine and Tegafur Uracil for Metastatic Colorectal Cancer. National Institute for Clinical Excellence, London, UK.
16. National Patient Safety Agency (2008) Rapid Response Report: Risk Of Incorrect Dosing of Oral Anti-Cancer Medications (NPSA/2008/RRR001). NPSA, London, UK.
17. O'Neill V.J. & Twelves C.J. (2002) Oral cancer treatment (developments in chemotherapy and beyond). British Journal of Cancer 87, 933-937.
18. O'Shaghnessy J., Miles D., Vujekila S., Moiseyenko V., Ayoub J.P., Cervantes G., Fumoleau P., Jones S., Lui W.Y., Mauriac L., Twelves C., Van Hazel G., Verma S. & Leonard R. (2002) Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer. Journal of Clinical Oncology 20, 2812-2823.
19. Oakley C., Lennan E., Roe H., Craven O., Harrold K. & Vidall C. (2010) Safe practice and nursing care of patients receiving oral anticancer medicines: a position statement from UKONS. Ecancer 4, 177. doi:10.3332/ecancer.2010.177.
20. Rau A.V. & Cohen H.J. (2008) Fatigue in older cancer patients: etiology, assessment and treatment. Seminars of Oncology 35, 633-642.
21. Sacks H., Chalmers T.C. & Smith H. (1982) Randomized versus historical controls for clinical trials. The American Journal of Medicine 72, 233-240.
22. Sacks H.S., Chalmers T.C. & Smith H., Jr (1983) Sensitivity and specificity of clinical trials. Randomized v historical controls. Archives of Internal Medicine 143, 753-755.
23. Vancutsem E., Twelves C., Cassidy J., Allman D., Bajetta E., Boyer M., Bugat R., Findlay M., Frings S., Jahn M., McKendrick J., Osterwalder B., Perez-Manga G., Rosso R., Rougier P., Schmiegel W.H., Seitz J.F., Thompson P., Vieitez J.M., Weitzel C., Harper P. & Xeloda Colorectal Cancer Study Group (2001) Oral capecitabine compared with intravenous fluoruracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. Journal of Clinical Oncology 19, 4097-4106.
24. Vidall C. (2010) Providing community oral chemotherapy services. European Journal of Cancer Care 19, 29-34.